Paolo Tombesi - Jul 27, 2022 Form 4 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
EVP & Chief Financial Officer
Signature
/s/ Brian Sun, Attorney-in-Fact
Stock symbol
TPTX
Transactions as of
Jul 27, 2022
Transactions value $
-$88,654
Form type
4
Date filed
7/29/2022, 04:18 PM
Previous filing
Feb 11, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Sale -$88.7K -1.18K -3.96% $74.94 28.7K Jul 27, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on July 26, 2021.